A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer (Q33391836)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer |
scientific article |
Statements
1 reference
A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer (English)
1 reference
Hoon Kyo Kim
1 reference
Sang Haak Lee
1 reference
Ju Sang Kim
1 reference
Seung Joon Kim
1 reference
Seok Chan Kim
1 reference
Young Kyoon Kim
1 reference
Hyun Hee Kang
1 reference
Hyoung Kyu Yoon
1 reference
Jeong Sup Song
1 reference
Hwa Sik Moon
1 reference
Jin Woo Kim
1 reference
Chi Hong Kim
1 reference
Byoung Yong Shim
1 reference
Der Sheng Sun
1 reference
Kwan Hyoung Kim
1 reference
15 September 2010
1 reference
1 reference
72
1 reference
64-67
1 reference
Identifiers
1 reference
1 reference